The current status of heart failure diagnostic biomarkers
View/ Open
File version
Accepted Manuscript (AM)
Author(s)
Zhang, Xi
Schulz, Benjamin L
Punyadeera, Chamindie
Year published
2016
Metadata
Show full item recordAbstract
Heart failure (HF) affects approximately 23 million individuals worldwide and this number is increasing, due to an aging and growing population. Early detection of HF is crucial in the management of this debilitating disease. Current diagnostic methods for HF rely heavily on clinical imaging techniques and blood analysis, which makes them less than ideal for population-based screening purposes. Studies focusing on developing novel biomarkers for HF have utilized various techniques and biological fluids, including urine and saliva. Promising results from these studies imply that these body fluids can be used in evaluating the ...
View more >Heart failure (HF) affects approximately 23 million individuals worldwide and this number is increasing, due to an aging and growing population. Early detection of HF is crucial in the management of this debilitating disease. Current diagnostic methods for HF rely heavily on clinical imaging techniques and blood analysis, which makes them less than ideal for population-based screening purposes. Studies focusing on developing novel biomarkers for HF have utilized various techniques and biological fluids, including urine and saliva. Promising results from these studies imply that these body fluids can be used in evaluating the clinical manifestation of HF and will one day be integrated into a clinical workflow and facilitate HF management.
View less >
View more >Heart failure (HF) affects approximately 23 million individuals worldwide and this number is increasing, due to an aging and growing population. Early detection of HF is crucial in the management of this debilitating disease. Current diagnostic methods for HF rely heavily on clinical imaging techniques and blood analysis, which makes them less than ideal for population-based screening purposes. Studies focusing on developing novel biomarkers for HF have utilized various techniques and biological fluids, including urine and saliva. Promising results from these studies imply that these body fluids can be used in evaluating the clinical manifestation of HF and will one day be integrated into a clinical workflow and facilitate HF management.
View less >
Journal Title
Expert Review of Molecular Diagnostics
Volume
16
Issue
4
Copyright Statement
This is an Author's Accepted Manuscript of an article published in the Expert Review of Molecular Diagnostics, 16 (4), pp. 487-500, 17 Feb 2016, copyright Informa UK Limited, trading as Taylor & Francis Group, available online at: https://doi.org/10.1586/14737159.2016.1144474
Subject
Clinical sciences
Cardiology (incl. cardiovascular diseases)
Science & Technology
Life Sciences & Biomedicine
Pathology
Biomarker
Diagnostic